Recombinantly expressed Plasmodium CelTOS antigen and methods of use thereof

  • US Patent No. 9120868
  • Issued: September 01, 2015
  • Status: Active
Medical & Biotechnology

A synthetic nucleotide, which transcribes as the cell-traversal protein for ookinetes and sporozoites (CelTOS) antigen of Malaria Plasmodium, and methods of use thereof.

Do you have questions or need more information on a specific technology? Let's talk.

Contact Us